Healthcare provider profile · identity verified

Brandy Leclere

Nurse Practitioner · CEDAR RAPIDS, IA · NPI 1932563061

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	244	61
Lisinopril	Lisinopril	162	43
Levothyroxine Sodium	Levothyroxine Sodium	161	44
Omeprazole	Omeprazole	143	35
Gabapentin	Gabapentin	111	25
Amlodipine Besylate	Amlodipine Besylate	110	33
Hydrochlorothiazide	Hydrochlorothiazide	108	30
Rosuvastatin Calcium	Rosuvastatin Calcium	99	32
Furosemide	Furosemide	77	23
Metformin Hcl	Metformin Hcl	76	23
Sertraline Hcl	Sertraline Hcl	73	19
Pantoprazole Sodium	Pantoprazole Sodium	72	20
Metoprolol Succinate	Metoprolol Succinate	71	23
Metformin Hcl Er	Metformin Hcl	69	21
Losartan Potassium	Losartan Potassium	68	18
Tramadol Hcl	Tramadol Hcl	67	18
Simvastatin	Simvastatin	64	21
Albuterol Sulfate Hfa	Albuterol Sulfate	61	20
Ozempic	Semaglutide	57	14
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Famotidine	Famotidine	49	14
Fluticasone Propionate	Fluticasone Propionate	47	17
Potassium Chloride	Potassium Chloride	45	13
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Trazodone Hcl	Trazodone Hcl	41	11
Glipizide Er	Glipizide	40	suppressed
Montelukast Sodium	Montelukast Sodium	40	11
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Allopurinol	Allopurinol	36	suppressed
Pregabalin	Pregabalin	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	13
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	31	11
Valacyclovir	Valacyclovir Hcl	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Diazepam	Diazepam	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Prednisone	Prednisone	26	24
Triamcinolone Acetonide	Triamcinolone Acetonide	26	15
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Eliquis	Apixaban	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Atenolol	Atenolol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Diclofenac Epolamine	Diclofenac Epolamine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Carvedilol	Carvedilol	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Azithromycin	Azithromycin	11	11
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error